نتایج جستجو برای: mineralocorticoid receptor

تعداد نتایج: 591331  

Journal: :Proceedings for Annual Meeting of The Japanese Pharmacological Society 2018

Journal: :Journal of the American College of Cardiology 2016

Journal: :Arteriosclerosis, Thrombosis, and Vascular Biology 2007

2014
Anne M. Dorrance

Aldosterone is a potent mineralocorticoid produced by the adrenal gland. Aldosterone binds to and activates the mineralocorticoid receptor (MR) in a plethora of tissues, but the cardiovascular actions of aldosterone are of primary interest clinically. Although MR antagonists were developed as antihypertensive agents, they are now considered to be important therapeutic options for patients with ...

Journal: :Journal of the American Society of Nephrology : JASN 2008
Matthew A Bailey Janice M Paterson Patrick W F Hadoke Nicola Wrobel Christopher O C Bellamy David G Brownstein Jonathan R Seckl John J Mullins

The syndrome of apparent mineralocorticoid excess arises from nonfunctional mutations in 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2), an enzyme that inactivates cortisol and confers aldosterone specificity on the mineralocorticoid receptor. Loss of 11betaHSD2 permits glucocorticoids to activate the mineralocorticoid receptor, and the hypertension in the syndrome is presumed to arise...

Journal: :JAMA 2015
Lauren B Cooper Bradley G Hammill Eric D Peterson Bertram Pitt Matthew L Maciejewski Lesley H Curtis Adrian F Hernandez

Consistency of LaboratoryMonitoring During Initiation ofMineralocorticoid Receptor Antagonist Therapy in PatientsWithHeart Failure Mineralocorticoid receptor antagonists (MRAs) are a cornerstone of heart failure therapy but have a risk of hyperkalemia. Clinical guidelines recommend close monitoring of renal function and electrolyte levels throughout the course of therapy.1 No large studies have...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید